Source: BioPortfolio

Renova Therapeutics: Renova Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14062018 Prices from USD $250

SummaryRenova Therapeutics Inc Renova is a drug development company that focuses on the development of peptide infusion therapies and gene therapy treatments for cardiovascular and metabolic diseases. The company's pipeline products include RT100 RT200 RT1...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Vijay Mahant's photo - CEO of Renova Therapeutics

CEO

Vijay Mahant

CEO Approval Rating

82/100

Read more